Non Invasive Prenatal Testing (NIPT) Market

Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024

Report Code: BT 5140 Sep, 2019, by marketsandmarkets.com

[144 Pages Report] The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

Non-Invasive Prenatal Testing (NIPT) Market-By Region

The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period

By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.

The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.

Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type). In 2018, trisomy was the largest application segment of the NIPT market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.

The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.

Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.

Non-Invasive Prenatal Testing (NIPT) Market-By Region

North America accounted for the largest share of the NIPT market in 2018.

Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region

Key Players in the Global NIPT Market

The NIPT market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

Illumina, Inc. (US)

Illumina is one of the major players in the non-invasive prenatal testing market. The company offers a range of highly interconnected products related to sequencing, genotyping, gene expression, and molecular diagnostics. It also offers whole-genome sequencing, genotyping, NIPT, and support services which further strengthen its market position.

Over the past three years, Illumina has launched several products to sustain its leading position in the NIPT market. For this purpose, the company has invested a significant amount of its revenue on R&D expenditure. In 2018, Illumina invested 18.6% of its revenue on R&D. In January 2019, Illumina expanded its NIPT platform portfolio with the launch of its VeriSeq NIPT Solution v2.

The company also focuses on inorganic strategies with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. Illumina is expected to grow at a high rate in the NIPT market during the forecast period, owing to its strong product portfolio, product innovation capabilities, and wide geographic presence.

Scope of the report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Product and Service, Application, and Region

Segments covered (NIPT products)

Method and End user

Geographies covered

North America (US and Canada), Europe (Germany, UK, France, and RoE), Asia, and the Rest of the World

Companies covered

Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

The research report categorizes the global NIPT market into the following segments and subsegments:

Non-invasive Prenatal Testing Market, by Product

  • Products
  • Consumables
  • Assay Kits & Reagents
  • Disposables
  • Instruments
  • NGS Systems
  • PCR Instruments
  • Microarrays
  • Ultrasound Devices
  • Other Instruments
  • Services

Note: Other instruments include centrifuges, UV systems, incubators, and microscopes.

Non-invasive Prenatal Testing Products Market, by Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests
  • Non-invasive Prenatal Testing Market, by Application
  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

Non-invasive Prenatal Testing Products Market, by End User

  • Diagnostic Laboratories
  • Hospitals

Non-invasive Prenatal Testing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia
  • Rest of the World (RoW)

Recent Developments

  • In June 2019, BGI and Eluthia (Germany) launched the NIFTY test (non-invasive prenatal test), under the brand name PreviaTest in Germany.
  • In January 2019, Illumina expanded its NIPT platform with the launch of VeriSeq NIPT Solution v2.
  • In November 2018, Illumina and Pacific Biosciences signed an agreement for Illumina to acquire Pacific Biosciences. This acquisition will allow Illumina to strengthen its sequencing solutions platform with accurate long-read sequencing capabilities.
  • In January 2017, Agilent Technology acquired Multiplicom N.V. (Belgium) in order to create comprehensive offerings for next-generation sequencing solutions. Multiplicom develops and commercializes molecular diagnostic solutions which are useful in the identification of congenital defects early in pregnancy and other genetic diseases

Key Questions Addressed by the Report

  • Where will all these developments take the industry in the mid to long-term?
  • What types of annual and multi-year partnerships are NIPT product and service companies exploring?
  • Which are the key players in the market and how intense is the competition?
  • Which are the recent contracts and agreements key players have signed?
  • What are the recent trends affecting NIPT product and service providers?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Non-Invasive Prenatal Testing: Market Overview
    4.2 Non-Invasive Prenatal Testing Market, By Application (2019–2024)
    4.3 Non-Invasive Prenatal Testing Market Share, By Method & Region (2018)
    4.4 Non-Invasive Prenatal Testing Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 34)
    5.1 Introduction
           5.1.1 Drivers
                    5.1.1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
                    5.1.1.2 Growing Preference for Noninvasive Techniques Over Invasive Methods
                    5.1.1.3 Improving Reimbursement Scenario for NIPT
                    5.1.1.4 Programs Focusing on Increasing the Awareness of NIPT
           5.1.2 Opportunities
                    5.1.2.1 Untapped Emerging Markets
           5.1.3 Challenges
                    5.1.3.1 Reliability of Test Results, Especially in Obese Women
                    5.1.3.2 Lack of Skilled Professionals

6 Non-Invasive Prenatal Testing Market, By Product & Service (Page No. - 40)
    6.1 Introduction
    6.2 Products
           6.2.1 Consumables
                    6.2.1.1 Assay Kits & Reagents
                               6.2.1.1.1 North America is the Largest Market for Assay Kits & Reagents Segments
                    6.2.1.2 Disposables
                               6.2.1.2.1 Use of Disposables to Avoid Contamination is One of the Major Growth Factors for This Segment
           6.2.2 Instruments
                    6.2.2.1 Ultrasound Devices
                               6.2.2.1.1 Popularity of Ultrasound in Fetal and Embryonic Imaging and Safety has Driven Market Growth
                    6.2.2.2 Next-Generation Sequencing Systems
                               6.2.2.2.1 Ngs Systems have Found Rising Use in NIPT
                    6.2.2.3 Polymerase Chain Reaction Instruments
                               6.2.2.3.1 Increasing Research in the Field of Prenatal Genetic Testing is Expected to Boost Market Growth
                    6.2.2.4 Microarrays
                               6.2.2.4.1 Flexibility of Chips and Short Processing Times have Supported the Use of Microarrays
                    6.2.2.5 Other Instruments
    6.3 Services
           6.3.1 North America Shows the Highest Demand for Testing Services

7 Non-Invasive Prenatal Testing Products Market, By Method (Page No. - 53)
    7.1 Introduction
    7.2 Ultrasound Detection
           7.2.1 Ultrasound Detection Segment Dominates the NIPT Products Market
    7.3 Biochemical Screening Tests
           7.3.1 High Incidence of Genetic Disorders & Increasing Focus on Prenatal Testing to Support Market Growth
    7.4 Cell-Free Dna in Maternal Plasma Tests
           7.4.1 Cell-Free Dna in Maternal Plasma Tests Segment to Register the Highest CAGR in the Forecast Period

8 Non-Invasive Prenatal Testing Market, By Application (Page No. - 61)
    8.1 Introduction
    8.2 Trisomy
           8.2.1 Trisomy Forms the Largest and Fastest-Growing Application Segment of the NIPT Market
    8.3 Microdeletion Syndrome
           8.3.1 High Incidence of Microdeletion Syndrome is A Key Factor Driving the Growth of This Application Segment
    8.4 Other Applications

9 Non-Invasive Prenatal Testing Products Market, By End User (Page No. - 68)
    9.1 Introduction
    9.2 Diagnostic Laboratories
           9.2.1 Increase in Research Intensity to Drive the Usage of NIPT Products Among Diagnostic Labs
    9.3 Hospitals
           9.3.1 North America Holds the Major Share of This End-User Segment

10 Non-Invasive Prenatal Testing Market, By Region (Page No. - 74)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 High Number of Babies Born With Chromosomal Syndromes is A Major Factor Driving the Demand for Non-Invasive Prenatal Testing in the US
             10.2.2 Canada
                        10.2.2.1 Unfavorable Reimbursement Scenario for Non-Invasive Prenatal Testing is A Key Challenge for Market Growth in Canada
     10.3 Europe
             10.3.1 France
                        10.3.1.1 Favorable Insurance Coverage for Prenatal Testing to Increase the Adoption of NIPT in France
             10.3.2 UK
                        10.3.2.1 High Incidence of Genetic Abnormalities to Increase the Demand for Prenatal Testing Procedures in the UK
             10.3.3 Germany
                        10.3.3.1 Increasing Healthcare Spending—A Major Factor Contributing to Market Growth in Germany
             10.3.4 Rest of Europe
     10.4 Asia
             10.4.1 High Cost of NIPT Products is A Major Factor Limiting Market Growth in Asia During the Forecast Period
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 104)
     11.1 Overview
     11.2 Market Player Ranking
     11.3 Competitive Leadership Mapping – Product Market
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Players
     11.4 Competitive Situation and Trends
             11.4.1 Product & Services Launches
             11.4.2 Expansions
             11.4.3 Acquisitions
             11.4.4 Other Strategies

12 Company Profile (Page No. - 112)
(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*
     12.1 Illumina, Inc.
     12.2 Thermo Fisher Scientific, Inc.
     12.3 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
     12.4 Perkinelmer, Inc.
     12.5 Agilent Technologies, Inc.
     12.6 Beijing Genomics Institute
     12.7 F. Hoffman-La Roche Ltd.
     12.8 Laboratory Corporation of America Holdings
     12.9 Natera, Inc.
     12.10 Yourgene Health

* Business Overview, Products and Services Offered, Recent Developments, and MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 137)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (112 Tables)

Table 1 Incidence Rate of Trisomy
Table 2 Risk of Down Syndrome With Increasing Maternal Age (Globally)
Table 3 Comparison of Non-Invasive and Invasive Prenatal Testing
Table 4 NIPT Reimbursement Scenario, By Country
Table 5 Public Healthcare Expenditure (% of GDP)
Table 6 Non-Invasive Prenatal Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 7 Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 8 Non-Invasive Prenatal Testing Products Market, By Region, 2017–2024 (USD Million)
Table 9 NIPT Consumables Market, By Type, 2017–2024 (USD Million)
Table 10 NIPT Consumables Market, By Region, 2017–2024 (USD Million)
Table 11 North America: NIPT Consumables Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: NIPT Consumables Market, By Country, 2017–2024 (USD Million)
Table 13 NIPT Assay Kits and Reagents Market, By Region, 2017–2024 (USD Million)
Table 14 NIPT Disposables Market, By Region, 2017–2024 (USD Million)
Table 15 NIPT Instruments Market, By Type, 2017–2024 (USD Million)
Table 16 NIPT Instruments Market, By Region, 2017–2024 (USD Million)
Table 17 North America: NIPT Instruments Market, By Country, 2017–2024 (USD Million)
Table 18 Europe: NIPT Instruments Market, By Country, 2017–2024 (USD Million)
Table 19 NIPT Ultrasound Devices Market, By Region, 2017–2024 (USD Million)
Table 20 NIPT Next-Generation Sequencing Systems Market, By Region, 2017–2024 (USD Million)
Table 21 NIPT Pcr Instruments Market, By Region, 2017–2024 (USD Million)
Table 22 NIPT Microarrays Market, By Region, 2017–2024 (USD Million)
Table 23 Other NIPT Instruments Market, By Region, 2017–2024 (USD Million)
Table 24 NIPT Services Market, By Region, 2017–2024 (USD Million)
Table 25 Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 26 Non-Invasive Prenatal Testing Products Market for Ultrasound Detection, By Region, 2017–2024 (USD Million)
Table 27 North America: Non-Invasive Prenatal Testing Products Market for Ultrasound Detection, By Country, 2017–2024 (USD Million)
Table 28 Europe: Non-Invasive Prenatal Testing Products Market for Ultrasound Detection, By Country, 2017–2024 (USD Million)
Table 29 Non-Invasive Prenatal Testing Products Market for Biochemical Screening Tests, By Region, 2017–2024 (USD Million)
Table 30 North America: Non-Invasive Prenatal Testing Products Market for Biochemical Screening Tests, By Country, 2017–2024 (USD Million)
Table 31 Europe: Non-Invasive Prenatal Testing Products Market for Biochemical Screening Tests, By Country, 2017–2024 (USD Million)
Table 32 Non-Invasive Prenatal Testing Products Market for cfDNA in Maternal Plasma Tests, By Region, 2017–2024 (USD Million)
Table 33 North America: Non-Invasive Prenatal Testing Products Market for cfDNA in Maternal Plasma Tests, By Country, 2017–2024 (USD Million)
Table 34 Europe: Non-Invasive Prenatal Testing Products Market for cfDNA in Maternal Plasma Tests, By Country, 2017–2024 (USD Million)
Table 35 Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 36 Non-Invasive Prenatal Testing Market for Trisomy, By Region, 2017–2024 (USD Million)
Table 37 North America: Non-Invasive Prenatal Testing Market for Trisomy, By Country, 2017–2024 (USD Million)
Table 38 Europe: Non-Invasive Prenatal Testing Market for Trisomy, By Country, 2017–2024 (USD Million)
Table 39 Non-Invasive Prenatal Testing Market for Microdeletion Syndrome, By Region, 2017–2024 (USD Million)
Table 40 North America: Non-Invasive Prenatal Testing Market for Microdeletion Syndrome, By Country, 2017–2024 (USD Million)
Table 41 Europe: Non-Invasive Prenatal Testing Market for Microdeletion Syndrome, By Country, 2017–2024 (USD Million)
Table 42 Non-Invasive Prenatal Testing Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 43 North America: Non-Invasive Prenatal Testing Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 44 Europe: Non-Invasive Prenatal Testing Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 45 Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 46 Non-Invasive Prenatal Testing Products Market for Diagnostic Laboratories, By Region, 2017–2024 (USD Million)
Table 47 North America: Non-Invasive Prenatal Testing Products Market for Diagnostic Laboratories, By Country, 2017–2024 (USD Million)
Table 48 Europe: Non-Invasive Prenatal Testing Products Market for Diagnostic Laboratories, By Country, 2017–2024 (USD Million)
Table 49 Non-Invasive Prenatal Testing Products Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 50 North America: Non-Invasive Prenatal Testing Products Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 51 Europe: Non-Invasive Prenatal Testing Products Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 52 Non-Invasive Prenatal Testing Market, By Region, 2017–2024 (USD Million)
Table 53 North America: Non-Invasive Prenatal Testing Market, By Country, 2017–2024 (USD Million)
Table 54 North America: Non-Invasive Prenatal Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 55 North America: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 56 North America: Non-Invasive Prenatal Testing Consumables Market, By Type, 2017–2024 (USD Million)
Table 57 North America: Non-Invasive Prenatal Testing Instruments Market, By Type, 2017–2024 (USD Million)
Table 58 North America: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 59 North America: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 60 North America: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 61 US: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 62 US: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 63 US: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 64 US: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 65 Canada: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 66 Canada: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 67 Canada: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 68 Canada: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 69 Europe: Non-Invasive Prenatal Testing Market, By Country, 2017–2024 (USD Million)
Table 70 Europe: Non-Invasive Prenatal Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 71 Europe: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 72 Europe: Non-Invasive Prenatal Testing Consumables Market, By Type, 2017–2024 (USD Million)
Table 73 Europe: Non-Invasive Prenatal Testing Instruments Market, By Type, 2017–2024 (USD Million)
Table 74 Europe: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 75 Europe: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 76 Europe: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 77 France: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 78 France: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 79 France: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 80 France: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 81 UK: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 82 UK: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 83 UK: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 84 UK: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 85 Germany: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 86 Germany: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 87 Germany: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 88 Germany: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 89 The Table Below Mentions the Mean Maternal Age at First Birth in RoE Countries:
Table 90 RoE: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 91 RoE: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 92 RoE: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 93 RoE: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 94 Asia: Non-Invasive Prenatal Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 95 Asia: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 96 Asia: Non-Invasive Prenatal Testing Consumables Market, By Type, 2017–2024 (USD Million)
Table 97 Asia: Non-Invasive Prenatal Testing Instruments Market, By Type, 2017–2024 (USD Million)
Table 98 Asia: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 99 Asia: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 100 Asia: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 101 RoW: Non-Invasive Prenatal Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 102 RoW: Non-Invasive Prenatal Testing Products Market, By Type, 2017–2024 (USD Million)
Table 103 RoW: Non-Invasive Prenatal Testing Consumables Market, By Type, 2017–2024 (USD Million)
Table 104 RoW: Non-Invasive Prenatal Testing Instruments Market, By Type, 2017–2024 (USD Million)
Table 105 RoW: Non-Invasive Prenatal Testing Products Market, By Method, 2017–2024 (USD Million)
Table 106 RoW: Non-Invasive Prenatal Testing Market, By Application, 2017–2024 (USD Million)
Table 107 RoW: Non-Invasive Prenatal Testing Products Market, By End User, 2017–2024 (USD Million)
Table 108 Product and Service Launches, 2016–2018
Table 109 Expansions, 2016–2018
Table 110 Acquisitions, 2016–2018
Table 111 Other Strategies, 2016–2018
Table 112 Exchange Rate (Used for the Conversion of Gbp to USD)


List of Figures (31 Figures)

Figure 1 Non-Invasive Prenatal Testing Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Non-Invasive Prenatal Testing Market, By Product & Service, 2019 vs 2024 (USD Million)
Figure 8 Non-Invasive Prenatal Testing Products Market, By Type, 2019 vs 2024 (USD Million)
Figure 9 Non-Invasive Prenatal Testing Products Market, By Method, 2019 vs 2024 (USD Million)
Figure 10 Non-Invasive Prenatal Testing Products Market, By End User, 2019 vs 2024 (USD Million)
Figure 11 Non-Invasive Prenatal Testing Market, By Application
Figure 12 Geographical Snapshot of the Non-Invasive Prenatal Testing Market
Figure 13 High Risk of Chromosomal Abnormalities With Increasing Maternal Age is A Major Factor Driving the Adoption of Non-Invasive Prenatal Testing
Figure 14 Trisomy is the Fastest-Growing Application Segment of the NIPT Market
Figure 15 Ultrasound Detection Segment Accounted for the Largest Market Share in 2018
Figure 16 The NIPT Market in Asia to Register the Highest Growth During the Forecast Period (2019–2024)
Figure 17 NIPT Market: Drivers, Opportunities, and Challenges
Figure 18 North America: Non-Invasive Prenatal Testing Market Snapshot
Figure 19 Europe: Non-Invasive Prenatal Testing Market Snapshot
Figure 20 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2016-2018
Figure 21 Global Non-Invasive Prenatal Testing Market Player Ranking for Product, 2018
Figure 22 NIPT Market – Product Market (Global) Competitive Leadership Mapping, 2018
Figure 23 Illumina, Inc.: Company Snapshot (2018)
Figure 24 Thermo Fisher Scientific, Inc.: Company Snapshot (2018)
Figure 25 GE Healthcare: Company Snapshot (2018)
Figure 26 Perkinelmer, Inc.: Company Snapshot (2018)
Figure 27 Agilent Technologies, Inc.: Company Snapshot (2018)
Figure 28 F. Hoffmann-La Roche Ltd.: Company Snapshot (2018)
Figure 29 Labcorp: Company Snapshot (2018)
Figure 30 Natera, Inc.: Company Snapshot (2018)
Figure 31 Yourgene Health.: Company Snapshot (2018)

The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global NIPT market. Secondary sources include directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

Non-Invasive Prenatal Testing (NIPT) Market-By Region

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global NIPT market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of NIPT products and services by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global NIPT market on the basis of product & service, application, and region
  • To define, describe, and forecast the global NIPT products market on the basis of method and end user
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as agreements, collaborations, & partnerships; product and service launches and approvals; acquisitions; and expansions in the NIPT market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for this report.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
BT 5140
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Non Invasive Prenatal Testing (NIPT) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home